fluspirilene has been researched along with Atherosclerotic Parkinsonism in 3 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frangos, H | 1 |
Zissis, NP | 1 |
Leontopoulos, I | 1 |
Diamantas, N | 1 |
Tsitouridis, S | 1 |
Gavriil, I | 1 |
Tsolis, K | 1 |
Tegeler, J | 1 |
Lehmann, E | 1 |
Weiher, A | 1 |
Heinrich, K | 1 |
Bulens, C | 1 |
Meerwaldt, JD | 1 |
van der Wildt, GJ | 1 |
Keemink, CJ | 1 |
1 trial available for fluspirilene and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluphenazine; Fluspir | 1978 |
2 other studies available for fluspirilene and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per week.
Topics: Akathisia, Drug-Induced; Anxiety Disorders; Benzodiazepines; Drug Administration Schedule; Drug Ther | 1990 |
Visual contrast sensitivity in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Therapy, Combination; Female; Fluspir | 1989 |